The Intrauterine Device: Still Misunderstood after All These Years

Southern Medical Journal

Volumn 93, Issue 9, 2000, Pages 859-864

  Cheng, Diana ^a,b  

^a Center for Maternal and Child Health   (United States)

^b Division of Health Services Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; CLASSIFICATION; DRUG INDUSTRY; ECONOMICS; EQUIPMENT DESIGN; FEMALE; HEALTH; HEALTH PERSONNEL ATTITUDE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LEGAL LIABILITY; MEDICAL EDUCATION; MIDDLE AGED; REVIEW; SAFETY; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; DRUG INDUSTRY; EDUCATION, MEDICAL; EQUIPMENT DESIGN; FEMALE; HUMANS; INTRAUTERINE DEVICES; LIABILITY, LEGAL; MIDDLE AGED; SAFETY; UNITED STATES; WORLD HEALTH;

EID: 0034263555     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200093090-00003     Document Type: Article

References (40)

1. Oppenheimer W: Prevention of pregnancy by the Grafenberg method: a re-evaluation after 28 years' experience. Am J Obstet Gynecol 1959; 78:446-454
2. Tatum JH, Schmidt FH, Phillips D, et al: The Dalkon shield controversy, structural and bacteriologic studies of IUD tails. JAMA 1973; 231:711-717
3. Trieman K, Liskin L, Kols A, et al: IUDs - an update. Population Reports, Series B, No. 5, Baltimore, Johns Hopkins School of Public Health Population Information Program, December 1995, pp 23-25
4. Piccinino L, Mosher W: Trends in contraceptive use in the United States: 1982-1995. Fam Plann Perspect 1998; 30:4-10,46
5. Trussell J: Contraceptive efficacy. Contraceptive Technology. Hatcher R, Trussell J, Stewart F, et al (eds). New York, Ardent Media Inc, 1998, p 800
6. Soderstrom R: Progestasert intrauterine progestone contraceptive system. Proceedings from the fourth International Conference on IUDs. Bardin CW, Mishell DR Jr (eds). Boston, Butterworth-Heinemann, 1994, pp 319-327
7. Rowe PJ: Research on intrauterine devices. World Health Organization. Special Programme of Research, Development and Research Training in Human Reproduction. Annual Technical Report. Geneva, World Health Organization, 1992, p 894
8. Peterson H, Xia Z, Hughes J, et al: The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative. Review of Sterilization. Am J Obstet Gynecol 1996; 174:1161-1170
9. Trussell J, Leveque JA, Koenig JD, et al: The economic value of contraception: a comparison of 15 methods. Am J Public Health 1995; 85:494-503
10. Alvior GT Jr: Pregnancy outcome with removal of intrauterine device. Obstet Gynecol 1973; 41:894
11. UK Family Planning Research Network: Pregnancy outcome associated with the use of IUDs. Br J Fam Plann 1989; 15:7-10
12. Atrash HK, Frye A, Hogue CJR: Incidence of morbidity and mortality with IUD in situ in the 1980s and 1990s. Proceedings from the Fourth International Congress on IUDs. Bardin GW, Mishell DR, Jr (eds). Boston, Butterworth-Heinemann, 1994, pp 76-87
13. Chaim W, Mazor M: Pregnancy with an intrauterine device in situ and preterm delivery. Arch Gynecol Obstet 1992; 252:21-24
14. World Health Organization: Improving access to quality care in family planning: medical eligibility criteria for initiating and continuing use of contraceptive methods. Geneva, World Health Organization, 1996
15. Office of Maternal Heahh and Family Planning: Tabulations from Reproductive and Perinatal Information/Data System; 1973 through 1998. Baltimore, Md, Department of Health and Mental Hygiene, 1999
16. Tabulations from 1973, 1978, 1983, 1988, 1993, and 1998 Ortho Birth Control Study. Raritan, NJ, Ortho-McNeil Pharmaceutical Corp, 1999
17. Farley TMM, Roseberg MJ, Rowe PJ, et al: Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339:785-788
18. Lee NC, Rubin GL, Ory HW, et al: Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol 1983; 62:1-6
19. Lee NC, Rubin GO, Borucki R: The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study. Obstet Gynecol 1988; 72:1-6
20. Daling JR, Weiss NS, Metch BJ, et al: Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med 1985; 312:937-941
21. Cramer DW, Schiff I, Schoenbaum SC, et al: Tubal infertility and the intrauterine device. N Engl J Med 1985; 312:941-947
22. Walsh T, Grimes D, Frezieres R, et al: Randomized controlled trial of prophylactic antibiotics before insertion of intrauterine devices. Lancet 1998; 351:1005-1008
23. Kookier CH, Scrutchfield FD: Barriers to prescribing the copper T 380A intrauterine device by physicians. West J Med 1990; 153:279-282
24. Burnhill MS: Utilization of intrauterine copper devices by patients of the Planned Parenthood Federation of America. Obstet Gynecol Surv 1996; 51:S52-S53
25. American College of Obstetricians and Gynecologists: Statement on Contraceptive Methods. Washington, DC, American College of Obstetricians and Gynecologists, July, 1998
26. WHO Scientific Group: Mechanism of action, safety and efficacy of intrauterine devices. Technical Report Series, No. 753. Geneva, World Health Organization, 1987
27. Alvarez F, Brache V, Fernandez E, et al: New insights on the mode of action of intrauterine contraceptive devices in women. Fertil Steril 1988; 49:768-773
28. Wilcox AJ, Weinberg CR, Armstrong EG, et al: Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay. Fertil Steril 1987; 47:265-269
29. Ortiz ME, Croxatto HB: The mode of action of IUDs. Contraception 1987; 36:37-03
30. Holland MK, White IG: Heavy metals and human spermatozoa, the toxicity of copper ions for spermatozoa. Contraception 1988; 38:685-695
31. Ortiz ME, Croxatto HB, Bardin CW: Mechanisms of action of intrauterine devices. Obstet Gynecol Surv 1996; 51(suppl 12):S42-S51
32. Sivin I: Dose and age dependent ectopic pregnancy risks with intrauterine contraception. Obstet Gynecol 1991; 78:291
33. Sivin I, Stern J, Coutinho E, et al: Prolonged intrauterine contraception: a seven year randomized study of the levonorgestrel 20 mcg/day (Lng 20) and the copper T 380 A IUDs. Contraception 1991; 44:474-480
34. Wilcox JC: A prospective New Zealand study of fertility after removal of copper intrauterine devices for conception and because of complications: a four year study. Am J Obstet Gynecol 1989; 160:391
35. Cheng D: Family planning training in Maryland family practice and obstetrics/gynecology residency programs. JAMWA 1999; 54:208-210
36. Steinauer J, DePineres T, Robert A, et al: Training family practice residents in abortion and other reproductive health care: a nationwide survey. Fam Plann Perspect 1997; 29:222-227
37. Westhoff C, Marks F, Rosenfield A: Residency training in contraception, sterilization and abortion. Obstet Gynecol 1993; 81:311-314
38. Forrest J: U.S. women's perceptions of and attitudes about the IUD. Obstet Gynecol Surv 1996; 51 (suppl):S30-S34
39. Luukkainen T, Toivonen J: Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception 1995; 52:269-276
40. Wildemeersch D, Batar I, Webb A, et al: GyneFix. the frameless intrauterine contraceptive implant - an update for interval, emergency, and postabortal contraception. 1999; 24:149-159